Page last updated: 2024-09-03

bay x 1005 and Leishmaniasis, Cutaneous

bay x 1005 has been researched along with Leishmaniasis, Cutaneous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henseleit, U; Rescher, U; Schönlau, F; Sorg, C; Steinbrink, K; Sunderkötter, C; Vogel, T1

Other Studies

1 other study(ies) available for bay x 1005 and Leishmaniasis, Cutaneous

ArticleYear
Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.
    Immunobiology, 2000, Volume: 202, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Calgranulin B; Cells, Cultured; Dexamethasone; Disease Models, Animal; Female; Immunohistochemistry; In Vitro Techniques; Interferon-gamma; Leishmania major; Leishmaniasis, Cutaneous; Lymph Nodes; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Fluorescence; Monocytes; Phagocytosis; Quinolines; S100 Proteins; Spleen

2000